Monday February 1, 2021 0 comments
LOUISVILLE -- Synergy Disc Replacement Ltd., announced it has enrolled the first patient in its U.S. IDE clinical trial.
The Synergy Disc trial is a multi-center, prospective, historically controlled study that will be conducted on 175 patients at up to 15 sites in the U.S.
This trial is designed to demonstrate that the Synergy Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion in patients with one-level symptomatic cervical degenerative disc disease (DDD).
Dr. Daniel Peterson at Austin Neurosurgeons in Austin, Texas has performed the first surgery utilizing the Synergy Disc in the United States.
“The Synergy Disc procedure is intuitive and forgiving,” said Peterson.
“I loved that I could see the immediate alignment correction -- the importance of which I cannot overstate. This is a fantastic next generation device.”
“We are extremely excited to announce the beginning of our U.S. clinical study and that Dr. Peterson has successfully performed the first Synergy Disc in the United States,” said Josh Butters, CEO of SDRi.
“We are honored to be working with Dr. Peterson and his research team on this effort.”
Dr. Neil Duggal, chief medical officer of SDRi added: “This is a huge milestone and achievement for our company, reflecting a tremendous amount of hard work by our entire team.”